The EMA Grants PRIME Designation to Viralym-M To Treat Viral Infections Linked to Stem Cell Transplant

  According to a recent article in The Pharma Letter, the European Medicines Agency (EMA) granted PRIME (PRIority MEdicines) designation to Viralym-M based on positive results from a Phase 2 proof-of-concept…

Continue Reading The EMA Grants PRIME Designation to Viralym-M To Treat Viral Infections Linked to Stem Cell Transplant
Toxic Protein Identified: Closing in on Alzheimer’s and Neurodegenerative Diseases
source: pixabay.com

Toxic Protein Identified: Closing in on Alzheimer’s and Neurodegenerative Diseases

  For years scientists have tried to understand how and why tau, well known to researchers for its implication in Alzheimer’s disease, changes from its normal form to a harmful…

Continue Reading Toxic Protein Identified: Closing in on Alzheimer’s and Neurodegenerative Diseases